This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
House Republicans have unveiled their plan to reshape Medicaid, looking for cost...
Fears that pharmaceuticals could yet be hit by tariffs have sent shares sharply ...
Move comes as government seeks to boost UK’s standing as drugs research leader
Medical devices like group’s surgical robots have already been hit by the new US...
US pharmaceutical group says patient in study experienced ‘potential drug-induce...
Latest executive order could shake up US pharma industry
Alis Biosciences then plans to list and offer big investors an easy way to sprea...
Promising late-stage trial results lift US pharmaceutical group’s shares almost 15%
Gavi says continued support would help American industry as well as save over 1m...
Swiss group becomes latest pharmaceutical company to promise investment in the f...
Vast majority of drugs prescribed in America are off-patent generics made in low...
Sweeping funding cuts threaten to undermine the innovation that has been a centr...
Novartis and Sanofi CEOs push for European benchmark against US prices
Pharmaceutical group says deal will help it establish leadership in treating rar...
Anglo-Swedish pharma company’s first-quarter earnings boosted by strong demand f...
Drugmaker says it can harness technology and change supply chain to guard agains...
A study co-authored by U.S. Food and Drug Administration scientists was released...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
The U.S. Department of Health and Human Services and FDA today announced a serie...
The U.S. Food and Drug Administration today welcomed HHS Secretary Robert F. Ken...
Renowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P...
Today, the U.S. Food and Drug Administration approved a novel treatment for hemo...
The FDA granted marketing authorization of the first diagnostic test for chlamyd...